Cargando…

325. Empiric Antibiotics for COVID-19 and the Utility of Procalcitonin

BACKGROUND: Bacterial coinfection in COVID-19 is infrequent, yet empiric antibiotic use is common. The objectives of this study were to investigate the effect of empiric antibiotics on time to resolution of COVID-19 pneumonia, elucidate the impact of COVID-19 on procalcitonin levels, and determine t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Desens, Adrienne D, Mohadjer, Kiya D, Thompson, Jessica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644000/ http://dx.doi.org/10.1093/ofid/ofab466.527

Ejemplares similares

2366. PCR Followed by Toxin EIA for the Diagnosis of C. difficile Infection
por: Zhang, Yu, et al.
Publicado: (2019)

P14 Procalcitonin evaluation of antibiotic use in COVID-19 hospitalized patients during the first wave of COVID-19: the PEACH study
por: Euden, Joanne, et al.
Publicado: (2022)

Effect of semi-quantitative procalcitonin assay on the adequacy of empirical antibiotics and mortality in septic patients
por: Dharaniyadewi, Dana, et al.
Publicado: (2013)

Optimization of antibiotic therapy by procalcitonin
por: Popov, D, et al.
Publicado: (2009)

419. Diagnostic Utility of a Ferritin to Procalcitonin Ratio to Differentiate Patients with COVID-19 from Those with Bacterial Pneumonia
por: Jankousky, Katherine C, et al.
Publicado: (2020)

163. MIC Shifts in Response to Increased Antibiotic Utilization During COVID-19 Pandemic
por: Byrd, Jonathan, et al.
Publicado: (2021)

325. Invasive and Non-Invasive Osteomyelitis Caused by Group B Streptococcus Infection Among Veterans
por: Bej, Taissa A, et al.
Publicado: (2020)

349. Diagnostic Testing and Antibiotic Utilization in Patients with COVID-19
por: Groft, Lauren, et al.
Publicado: (2021)

209. Antibiotic Utilization During the COVID-19 Surge in Detroit
por: Shallal, Anita, et al.
Publicado: (2020)

1479. Evaluating the Impact of Procalcitonin on Antibiotic Utilization in Chronic Obstructive Pulmonary Disease Exacerbations
por: Lin, Kevin, et al.
Publicado: (2018)

119. Procalcitonin to Guide Antibiotic Therapy for Respiratory Infection: A Systematic Review of Systematic Reviews
por: York, Joshua A, et al.
Publicado: (2020)

356. The Role of Procalcitonin in Antimicrobial Stewardship Among Cancer Patients Admitted with COVID-19
por: Dagher, Hiba, et al.
Publicado: (2021)

80. Pharmacoeconomic Analysis Comparing the Empiric Utilization of Cefepime Versus Piperacillin/tazobactam
por: Olmack, Kelsey, et al.
Publicado: (2020)

1339. Impact of Implementing Procalcitonin Testing with Comprehensive Education on Procalcitonin Ordering Habits and Antibiotic Usage
por: Johnsrud, Joyce, et al.
Publicado: (2019)

325. Neurosyphilis Management in the Post-Procaine Penicillin Era
por: Cannon, Chase, et al.
Publicado: (2018)

P36 Procalcitonin as an antimicrobial stewardship tool in the COVID-19 era: a single centre experience
por: Creedon, Margaret, et al.
Publicado: (2022)

127. Living on the Edge: The Impact of MIC Distributions on Empiric Antibiotic Selection
por: Bauer, Karri A, et al.
Publicado: (2021)

406. Utility of Tracheal Aspirates in Guiding Antibiotic Use in Mechanically Ventilated Patients with COVID-19
por: Shihadeh, Katherine C, et al.
Publicado: (2020)

74. Empiric Antibiotic Therapy and Community-onset Bacterial Co-infection in Patients Hospitalized with COVID-19: A Multi-hospital Cohort Study
por: Vaughn, Valerie, et al.
Publicado: (2020)

142. Frequency of Short-course Empiric Antibiotic Use as an Antimicrobial Stewardship Metric
por: McGregor, Jessina C, et al.
Publicado: (2020)

1680. Evaluation of the Urinalysis Reflex to Culture Sensitivity and Impact on Antibiotic Utilization
por: Wellen, Jacob, et al.
Publicado: (2020)

325. Outcomes of Outpatient Parenteral Antimicrobial Therapy in the Solid Organ Transplant Population
por: Dillon, William P, et al.
Publicado: (2023)

Use of procalcitonin as an aid to antibiotic prescribing in intensive care
por: Fletcher, A, et al.
Publicado: (2008)

325 Use of simulation to prepare providers for emergent cesarean delivery in a patient with COVID-19
por: Newman, Rachel A., et al.
Publicado: (2021)

177. User Preferences for Visualization of Antibiogram Data in Clinical Practice for Empiric Prescription of Antibiotics
por: Vingino, Alexandria R, et al.
Publicado: (2021)

325. Cancer Screening Disparities among Persons Living with HIV (PLWH)
por: Hysell, Kristen, et al.
Publicado: (2019)

391. Outcomes of Empiric Antimicrobial Therapy in COVID-19 Positive Patients
por: Medler, Corey J, et al.
Publicado: (2020)

Su325 HEPATIC STEATOSIS MAY LEAD TO WORSE OUTCOMES IN PATIENTS WITH LIVER INJURY AND COVID-19
por: Shaikh, Danial H., et al.
Publicado: (2021)

149. Impact of Stewardship on Antibiotic Utilization Rates During the COVID-19 Pandemic: Successes and Challenges in a Regional Hospital
por: Macias, Ana, et al.
Publicado: (2021)

785. Bacterial Co-infection and Empirical Antibiotic Therapy in Patients with COVID-19
por: Lee, Jiyoung, et al.
Publicado: (2022)

Impact of Procalcitonin (PCT)-Guided Antibiotic Management on Antibiotic Exposure and Outcomes: Real World Evidence
por: Broyles, Michael
Publicado: (2017)

P12 Partial implementation of procalcitonin measurement as an antibiotic stewardship in the ICU
por: Gill, Simon, et al.
Publicado: (2023)

1992. Initial Procalcitonin Level and Antibiotic Practice Patterns Among Patients with Acute Respiratory Infections
por: Costales, Jessica K, et al.
Publicado: (2019)

325. Molecular Characterization of Antimicrobial Resistance Genes in Neisseria gonorrhoeae in Southeast Michigan
por: Shallal, Anita, et al.
Publicado: (2022)

The utility of procalcitonin for the patients with infected pancreatic necrotic and pancreatic abscess
por: Adachi, T, et al.
Publicado: (2015)

112. Impact of Respiratory Viral PCR Panels (RVP) and Serum Procalcitonin (PCT) on Antibiotic Days of Therapy (DOT) in Patients Admitted with Lower Respiratory Tract Infections (LRTI)
por: Bilinskaya, Anastasia, et al.
Publicado: (2020)

2194. Procalcitonin-Guided Antibiotic Strategy for Lower Respiratory Tract Infections: Outcomes and Safety of Withholding Antibiotics
por: Bambino Geno Tai, Don, et al.
Publicado: (2019)

Procalcitonin to guide length of antibiotic therapy in surgical intensive care patients
por: Schroeder, S, et al.
Publicado: (2008)

227. Evaluation of Empiric Vancomycin Utilization at 72 Hours Post Admission: is De-escalation of Vancomycin Appropriate?
por: Naderi, Mandana, et al.
Publicado: (2020)

103. Empiric Antibiotic Susceptibility Using a Traditional vs. Syndromic Antibiogram-Implications for Antimicrobial Stewardship Programs
por: Klinker, Kenneth, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ue8r325rn1sb4v5uobdre0i9d3